Literature DB >> 186194

Effect of isoproterernol and aminiphylline on cyclic AMP levels of guinea pig macrophages.

T J Higgins, J R David.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 186194     DOI: 10.1016/0008-8749(76)90147-7

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


× No keyword cloud information.
  6 in total

Review 1.  Sympathetic modulation of immunity: relevance to disease.

Authors:  Denise L Bellinger; Brooke A Millar; Sam Perez; Jeff Carter; Carlo Wood; Srinivasan ThyagaRajan; Christine Molinaro; Cheri Lubahn; Dianne Lorton
Journal:  Cell Immunol       Date:  2008-03-04       Impact factor: 4.868

2.  Chronologic changes of activities of naphthol AS-D acetate esterase and other nonspecific esterases in the mononuclear phagocytes of tuberculous lesions.

Authors:  T Tsuda; M Ando; K Shima; M Sugimoto; O Onizuka; H Tokuomi
Journal:  Am J Pathol       Date:  1979-11       Impact factor: 4.307

3.  Interaction with receptor for activated C-kinase 1 (RACK1) sensitizes the phosphodiesterase PDE4D5 towards hydrolysis of cAMP and activation by protein kinase C.

Authors:  Rebecca J Bird; George S Baillie; Stephen J Yarwood
Journal:  Biochem J       Date:  2010-11-15       Impact factor: 3.857

4.  Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood.

Authors:  T van der Poll; J Jansen; E Endert; H P Sauerwein; S J van Deventer
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

Review 5.  Autonomic nervous system and immune system interactions.

Authors:  M J Kenney; C K Ganta
Journal:  Compr Physiol       Date:  2014-07       Impact factor: 9.090

6.  125I-8-L-arginine vasopressin binding to human mononuclear phagocytes.

Authors:  L H Block; R Locher; W Tenschert; W Siegenthaler; T Hofmann; E Mettler; W Vetter
Journal:  J Clin Invest       Date:  1981-08       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.